- Home
- KALA vs REE Comparison
KALA vs REE Comparison
Compare KALA & REE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- REE
- Stock Information
- Founded
- KALA 2009
- REE 2011
- Country
- KALA United States
- REE Israel
- Employees
- KALA N/A
- REE N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- REE Auto Manufacturing
- Sector
- KALA Health Care
- REE Consumer Discretionary
- Exchange
- KALA Nasdaq
- REE Nasdaq
- Market Cap
- KALA 26.2M
- REE 22.4M
- IPO Year
- KALA 2017
- REE N/A
- Fundamental
- Price
- KALA $0.81
- REE $1.18
- Analyst Decision
- KALA Buy
- REE Strong Buy
- Analyst Count
- KALA 3
- REE 2
- Target Price
- KALA $31.50
- REE $11.75
- AVG Volume (30 Days)
- KALA 1.3M
- REE 1.1M
- Earning Date
- KALA 11-07-2025
- REE 12-16-2025
- Dividend Yield
- KALA N/A
- REE N/A
- EPS Growth
- KALA N/A
- REE N/A
- EPS
- KALA N/A
- REE N/A
- Revenue
- KALA N/A
- REE $183,000.00
- Revenue This Year
- KALA N/A
- REE $327.73
- Revenue Next Year
- KALA N/A
- REE $36,888.82
- P/E Ratio
- KALA N/A
- REE N/A
- Revenue Growth
- KALA N/A
- REE N/A
- 52 Week Low
- KALA $0.77
- REE $0.53
- 52 Week High
- KALA $20.60
- REE $11.72
- Technical
- Relative Strength Index (RSI)
- KALA 26.24
- REE 60.81
- Support Level
- KALA $0.77
- REE $1.14
- Resistance Level
- KALA $1.52
- REE $1.41
- Average True Range (ATR)
- KALA 0.10
- REE 0.18
- MACD
- KALA 0.31
- REE 0.00
- Stochastic Oscillator
- KALA 4.56
- REE 38.94
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is in early stages of commercialization and develop and produce software-defined vehicle (SDV) technology that manages vehicle operations and features through proprietarily-developed software. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.